Small caps continue to have attractive valuations heading into 2026. Compared to large caps on a relative basis, small caps are significantly cheaper today than they were in most time periods. It is ...

Investing.com -- Morgan Stanley told clients in a recent note that improving fundamentals continue to support small-cap ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Ooops... Something went wrong while loading this page.

Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The US equity ...

The Artisan Mid Cap Fund outpaced the Russell Midcap Growth Index in Q4 2025 despite a modest negative absolute return. Read ...

Corvus Pharmaceuticals soars on promising Phase 1 data for soquelitinib. But CRVS shares may not be able to sustain today's ...

Here's Wilson's biggest worry over the Greenland crisis: "The more notable risk is tied to whether we see the EU activate its ...

Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.

In the pivotal clinical trial of their technology, researchers at Orlucent®, Inc. have confirmed the accuracy of the company's Skin Fluorescent Imaging (SFI) System, a non-invasive, hand-held ...

Eli Lilly & Company LLY and Pfizer PFE are large-cap U.S. pharmaceutical leaders, each backed by diversified product ...